Back to Search
Start Over
A case of Anti‐MDA5‐Positive dermatomyositis after inactivated COVID‐19 vaccine.
- Source :
- Journal of the European Academy of Dermatology & Venereology; Feb2023, Vol. 37 Issue 2, pe127-e129, 3p
- Publication Year :
- 2023
-
Abstract
- COVID-19 mRNA vaccine-associated dermatomyositis (DM) with the anti-TIF-1y-positive case was first reported in 2021.[2] Two reports about MDA5-DM patients after mRNA or adenovirus vector COVID-19 vaccines were searched out in the PubMed, Science Direct and SCOPUS by June 2022.[[3]] We first reported an MDA5-DM with rapid progressive interstitial lung disease (RP-ILD) patient after an inactivation COVID-19 vaccine, exhibiting time course of the disease development. Dear Editor, During the epidemic of COVID-19 disease worldwide, applying COVID-19 vaccination can effectively protect humans from serious symptoms and help reduce long-term effects.[1] However, COVID-19 vaccines have been linked to some potential side effects. A case of Anti-MDA5-Positive dermatomyositis after inactivated COVID-19 vaccine. [Extracted from the article]
- Subjects :
- COVID-19 vaccines
MYOSITIS
DERMATOMYOSITIS
COVID-19
Subjects
Details
- Language :
- English
- ISSN :
- 09269959
- Volume :
- 37
- Issue :
- 2
- Database :
- Complementary Index
- Journal :
- Journal of the European Academy of Dermatology & Venereology
- Publication Type :
- Academic Journal
- Accession number :
- 161310871
- Full Text :
- https://doi.org/10.1111/jdv.18653